Effect of S-1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7-year multicenter observational cohort study in Taiwan.

Hsiang-Lan LaiYen-Yang ChenChang-Hsien LuChia-Yen HungYung-Chia KuoJen-Shi ChenHung-Chih HsuPing-Tsung ChenPei-Hung ChangYu-Shin HungWen-Chi Chou

Published in: Cancer medicine (2019)

Our results support the clinical use of S-1 as the treatment of choice for patients with locally advanced or metastatic pancreatic cancer, particularly in resource-limited situations.

Keyphrases

locally advanced
squamous cell carcinoma
rectal cancer
small cell lung cancer
neoadjuvant chemotherapy
radiation therapy
cross sectional
phase ii study
double blind
lymph node
replacement therapy
smoking cessation